ASH 2020: Dr. Jennifer Brown on combination duvelisib + venetoclax for patients with relapsed/refractory chronic lymphocytic leukemia (CLL)
The American Society of Hematology is a non-profit organization involving blood cancer physicians, researchers and healthcare stakeholders and is the world leader in promoting and supporting clinical and scientific hematology research. Its Annual December Meeting provides a prestigious forum for the peer-reviewed presentation of ground-breaking and cutting-edge data. In this video, Dr. John Pagel states emphatically that this CLL data should be known by all CLL patients and their caregivers.
Related posts